A Study of Treatment Patterns and Clinical Outcomes of Psoriasis in Japan
NCT04826536 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114
Last updated 2022-06-03
Summary
The purpose of this study is to understand current real-world treatment patterns and clinical outcomes, reasons for switching treatment, and participant characteristics using each systemic psoriasis treatment in Japan.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-25
- Primary Completion
- 2021-10-08
- Completion
- 2021-10-08
Countries
- Japan
More Related Trials
-
Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis
NCT05268016 ·Status: COMPLETED ·Phase: PHASE2
-
LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis
NCT02668692 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of BFH772 in Psoriasis Patients
NCT00987870 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis
NCT02274363 ·Status: COMPLETED
-
A Phase 3 Clinical Study of KHK4827
NCT01782924 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Clinical Study of KHK 4827
NCT02052609 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
NCT06382987 ·Status: RECRUITING
-
STA-21 Topical Efficacy on Psoriasis
NCT01047943 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy
NCT06102356 ·Status: COMPLETED
-
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects
NCT06308393 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
NCT00358384 ·Status: COMPLETED ·Phase: PHASE1
-
LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris
NCT02888236 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis
NCT00823693 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
NCT02239666 ·Status: COMPLETED
-
Topical CP-690,550 For Chronic Plaque Psoriasis
NCT00678561 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
NCT07261306 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris
NCT03806790 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)
NCT01882647 ·Status: COMPLETED ·Phase: PHASE3
-
Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis
NCT03156062 ·Status: UNKNOWN ·Phase: NA
-
Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
NCT02933866 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy
NCT03930186 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients
NCT04765332 ·Status: COMPLETED
-
A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis
NCT01488201 ·Status: COMPLETED ·Phase: PHASE1